Streetbeat News

DNA

Ginkgo Bioworks Holdings, Inc.

https://www.ginkgobioworks.com

Industry

Biotechnology

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Open

7.21

Mkt cap

367M

Volume

High

7.21

P/E Ratio

-0.35

52-wk high

75.20

Low

6.01

Div yield

N/A

52-wk low

5.26

Ginkgo BioWorks and XWELL are expanding their collaboration with the U.S. Centers for Disease Control and Prevention's traveler-based genomic surveillance program. They will now test for more than 30 additional priority pathogens, besides SARS-COV-2.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:15 pm

Ginkgo Bioworks (NYSE:DNA) and the Government of Serbia have announced a Memorandum of Understanding (MoU) to collaborate in support of Serbia's bioeconomy vision. The partnership will establish a Startup Accelerator that leverages Ginkgo's platform and expertise to support Serbian companies in the bioeconomy sector. The collaboration will also explore partnerships to develop and implement new biomonitoring capabilities in Serbia. Companies at Serbia's BIO4 campus will have opportunities to engage Ginkgo staff and access Ginkgo expertise on site.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:02 pm

QL AG has entered into a collaboration with Ginkgo Bioworks to develop dairy proteins. QL AG will leverage Ginkgo's strain engineering capabilities to provide the market with high-quality, nutritionally equivalent dairy proteins.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:03 am

Ark Invest, led by Cathie Wood, made significant purchases of shares in Block Inc, Archer Aviation, and CRISPR Therapeutics on Monday. The fund also bolstered its positions in Pacific Biosciences of California, Ginkgo Bioworks Holdings, and Markforged Holding Corp. The purchases were made through various Ark ETFs, including ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Autonomous Technology & Robotics ETF, and ARK Genomic Revolution ETF.

Portfolio Pulse from Benzinga Neuro

October 10, 2023 | 2:45 am

Ark Invest, led by Cathie Wood, sold over $25 million worth of Tesla Inc shares on October 4, 2023. The shares were sold through ARK Innovation ETF, ARK Autonomous Technology & Robotics ETF, and ARK Next Generation Internet ETF. This move is a significant shift from Ark's previous bullish stance on Tesla. Additionally, Ark Invest made other key trades, including the purchase of shares in Pacific Biosciences of California, CRISPR Therapeutics AG, and Ginkgo Bioworks Holdings Inc, and the sale of Nvidia Corporation shares.

Portfolio Pulse from Benzinga Neuro

October 05, 2023 | 1:54 am

Zymergen, a subsidiary of Ginkgo Bioworks, has filed for Chapter 11 bankruptcy. Ginkgo, which is not filing for bankruptcy, ended Q2 2023 with $1.1 billion in cash and remains well-capitalized. Ginkgo has also entered into an asset purchase agreement with Zymergen to acquire exclusive rights to most of Zymergen's intellectual property assets and certain other assets.

Portfolio Pulse from Charles Gross

October 03, 2023 | 10:59 am

Nosh.bio has partnered with Ginkgo Bioworks to enhance the meaty taste of its mycoprotein products. The partnership will leverage Ginkgo's strain optimization services to improve the flavor profile of Nosh.bio's products.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:07 am

Ginkgo Bioworks and Texas A&M University have been jointly awarded a research grant from the USDA APHIS via the NIFA AFRI to study SARS-CoV-2 in white-tailed deer populations in Texas. This news has led to an increase in Ginkgo Bioworks' share prices.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 4:05 pm

Ginkgo Bioworks and Texas A&M University have jointly received a research grant from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service. The grant is to study SARS-CoV-2 in white-tailed deer populations in Texas.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 11:07 am

Several US stocks recorded gains in Wednesday's trading session. MillerKnoll surged 27% after announcing better-than-expected Q1 results and FY24 EPS guidance above estimates. Biohaven, Ramaco Resources, SoundHound AI, Warrior Met Coal, Immunovant, PROS Holdings, Ginkgo Bioworks, Hayward Holdings, Sea Limited, TAL Education Group, Opendoor Technologies, WW International, IonQ, Stevanato Group, Peabody Energy Corporation, and Mattel also saw significant increases.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 2:28 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.